2 completed, 2 recruiting, 2 withdrawn. 6 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 2, Recruiting 2, Withdrawn 2 |
| Phase 1 | 2 | Withdrawn 2 |
Follow Agendia: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Gene Signatures to Guide HR+MBC Therapy in a Diverse Cohort Capecitabine, Endocrine-therapy, MammoPrint ® and BluePrint assays - Invasive Mammary Carcinoma, Metastatic Breast Cancer | Phase 2 | Recruiting | Sonya Reid | 64 | 2023-09-28 | 2026-01-20 |
| Deescalation of Endocrine Therapy Duration in Women With HR+ HER2- Breast Cancer at Very Low Risk Anti-aromatase inhibitor - Breast Cancer | Phase 2 | Recruiting | UNICANCER | 696 | 2022-10-12 | 2026-07-21 |
| LY3200882 and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer (EORTC1615) LY3200882 - Colorectal Cancer Metastatic | Phase 1 / Phase 2 | Withdrawn | The Netherlands Cancer Institute | 2020-01-01 | 2025-09-05 | |
| The Effects of Short-term Preoperative Treatment With Hormonal Therapy on Gene Profiles in Breast Cancer Tamoxifen Citrate, Letrozole, Exemestane - Breast Cancer | Phase 2 | Completed | Johns Hopkins University | 30 | 2019-02-20 | 2024-05-07 |
| Galunisertib and Capecitabine in Advanced Resistant TGF-beta Activated Colorectal Cancer Galunisertib - Colorectal Cancer Metastatic | Phase 1 / Phase 2 | Withdrawn | The Netherlands Cancer Institute | 2018-08-24 | 2019-07-24 | |
| Vinorelbine in Advanced BRAF-like Colon Cancer Vinorelbine Tartrate - Colon Cancer | Phase 2 | Completed | The Netherlands Cancer Institute | 1 | 2018-03-01 | 2025-08-03 |
Breast Neoplasms (3) · Colonic Neoplasms (1)
Capecitabine (3) · LY-2157299 (1) · Letrozole (1) · Tamoxifen (1) · Vinorelbine (1) · exemestane (1)
Netherlands (2) · United States (2) · France (1)
A Bardelli, Prof (3) · A Cervantes, Prof (3) · J Tabernero, Prof (3) · R Bernards, Prof (3) · R Salazar, MD, PhD (3) · S Siena, Prof (3) · S Tejpar, Prof (3) · F Ciardiello, Prof (2) · F Ciardello, Prof (1) · Mehran Habibi, MD (1) · N Steeghs, MD, PhD (1) · Sonya Reid, MD (1)
2016 (1)